Lung function measurements in rodents in safety pharmacology studies

The ICH guideline S7A requires safety pharmacology tests including measurements of pulmonary function. In the first step – as part of the core battery - lung function tests in conscious animals are requested. If potential adverse effects raise concern for human safety, these should be explored in a...

Full description

Bibliographic Details
Main Author: Heinz Gerd Hoymann
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00156/full
_version_ 1818016707615129600
author Heinz Gerd Hoymann
author_facet Heinz Gerd Hoymann
author_sort Heinz Gerd Hoymann
collection DOAJ
description The ICH guideline S7A requires safety pharmacology tests including measurements of pulmonary function. In the first step – as part of the core battery - lung function tests in conscious animals are requested. If potential adverse effects raise concern for human safety, these should be explored in a second step as a follow-up study. For these two stages of safety pharmacology testing, both noninvasive and invasive techniques are needed which should be as precise and reliable as possible. A short overview of typical in-vivo measurement techniques is given, their advantages and disadvantages are discussed and out of these the noninvasive head-out body plethysmography and the invasive but repeatable body-plethysmography in orotracheally intubated rodents are presented in detail. For validation purposes the changes in the respective parameters such as tidal midexpiratory flow (EF50) or lung resistance have been recorded in the same animals in typical bronchoconstriction models and compared. In addition, the technique of head-out body plethysmography has been shown to be useful to measure lung function in juvenile rats starting from day two of age. This allows safety pharmacology testing and toxicological studies in juvenile animals as a model for the young developing organism as requested by the regulatory authorities (e.g. EMEA Guideline 1/2008).It is concluded that both invasive and noninvasive pulmonary function tests are capable of detecting effects and alterations on the respiratory system with different selectivity and area of operation. The use of both techniques in a large number of studies in mice and rats in the last years have demonstrated that they provide useful and reliable information on pulmonary mechanics in safety pharmacology and toxicology testing, in investigations of respiratory disorders, and in pharmacological efficacy studies.
first_indexed 2024-04-14T07:16:17Z
format Article
id doaj.art-bfd77fe656e34552b788c7e541215ed0
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-14T07:16:17Z
publishDate 2012-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-bfd77fe656e34552b788c7e541215ed02022-12-22T02:06:18ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122012-08-01310.3389/fphar.2012.0015630094Lung function measurements in rodents in safety pharmacology studiesHeinz Gerd Hoymann0Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM)The ICH guideline S7A requires safety pharmacology tests including measurements of pulmonary function. In the first step – as part of the core battery - lung function tests in conscious animals are requested. If potential adverse effects raise concern for human safety, these should be explored in a second step as a follow-up study. For these two stages of safety pharmacology testing, both noninvasive and invasive techniques are needed which should be as precise and reliable as possible. A short overview of typical in-vivo measurement techniques is given, their advantages and disadvantages are discussed and out of these the noninvasive head-out body plethysmography and the invasive but repeatable body-plethysmography in orotracheally intubated rodents are presented in detail. For validation purposes the changes in the respective parameters such as tidal midexpiratory flow (EF50) or lung resistance have been recorded in the same animals in typical bronchoconstriction models and compared. In addition, the technique of head-out body plethysmography has been shown to be useful to measure lung function in juvenile rats starting from day two of age. This allows safety pharmacology testing and toxicological studies in juvenile animals as a model for the young developing organism as requested by the regulatory authorities (e.g. EMEA Guideline 1/2008).It is concluded that both invasive and noninvasive pulmonary function tests are capable of detecting effects and alterations on the respiratory system with different selectivity and area of operation. The use of both techniques in a large number of studies in mice and rats in the last years have demonstrated that they provide useful and reliable information on pulmonary mechanics in safety pharmacology and toxicology testing, in investigations of respiratory disorders, and in pharmacological efficacy studies.http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00156/fullPharmacologyMouseratexperimental animal modelsirritant potentialjuvenile models
spellingShingle Heinz Gerd Hoymann
Lung function measurements in rodents in safety pharmacology studies
Frontiers in Pharmacology
Pharmacology
Mouse
rat
experimental animal models
irritant potential
juvenile models
title Lung function measurements in rodents in safety pharmacology studies
title_full Lung function measurements in rodents in safety pharmacology studies
title_fullStr Lung function measurements in rodents in safety pharmacology studies
title_full_unstemmed Lung function measurements in rodents in safety pharmacology studies
title_short Lung function measurements in rodents in safety pharmacology studies
title_sort lung function measurements in rodents in safety pharmacology studies
topic Pharmacology
Mouse
rat
experimental animal models
irritant potential
juvenile models
url http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00156/full
work_keys_str_mv AT heinzgerdhoymann lungfunctionmeasurementsinrodentsinsafetypharmacologystudies